share_log

中基長壽科學:有關二零二五年循環貸款協議之須予披露及持續關連交易之澄清公告

ZHONG JI LS: CLARIFICATION ANNOUNCEMENT IN RELATION TODISCLOSEABLE AND CONTINUING CONNECTEDTRANSACTION IN RELATION TOTHE 2025 REVOLVING LOAN AGREEMENT

HKEX ·  Nov 15, 2024 16:31

Summary by Moomoo AI

中基長壽科學集團有限公司(「中基長寿科学」)於2024年11月15日澄清,其先前於2024年11月11日公告的2025年循環貸款協議,實際上構成上市規則第14章下的主要交易,而非僅是須予披露交易。該公司指出,相關百分比率超過25%但低於100%,因此該持續關連交易需要遵守申報、公告、年度審閱、通函及獨立股東批准的規定。董事會成員包括執行董事閆立(主席)、閆一帆(行政總裁)、李小雙、曹衆,以及非執行董事何亦武博士、呂長勝先生,和獨立非執行董事李思先生、黃江先生、黃慈波教授。
中基長壽科學集團有限公司(「中基長寿科学」)於2024年11月15日澄清,其先前於2024年11月11日公告的2025年循環貸款協議,實際上構成上市規則第14章下的主要交易,而非僅是須予披露交易。該公司指出,相關百分比率超過25%但低於100%,因此該持續關連交易需要遵守申報、公告、年度審閱、通函及獨立股東批准的規定。董事會成員包括執行董事閆立(主席)、閆一帆(行政總裁)、李小雙、曹衆,以及非執行董事何亦武博士、呂長勝先生,和獨立非執行董事李思先生、黃江先生、黃慈波教授。
Zhong ji ls Group Limited ("Zhong ji ls") clarified on November 15, 2024, that its previously announced revolving loan agreement for 2025 on November 11, 2024, actually constitutes a major transaction under Chapter 14 of the listing rules, rather than merely a disclosable transaction. The company indicated that the relevant percentage exceeds 25% but is less than 100%, thus this ongoing connected transaction is required to comply with the provisions of disclosure, announcement, annual review, circular, and independent shareholder approval. The board of directors includes executive directors Yan Li (Chairman), Yan Yifan (CEO), Li Xiaoshuang, Cao Zhong, as well as non-executive directors Dr. He Yiwu, Mr. Lü Changsheng, and independent non-executive directors Mr. Li Si, Mr. Huang Jiang, and Professor Huang Cibo.
Zhong ji ls Group Limited ("Zhong ji ls") clarified on November 15, 2024, that its previously announced revolving loan agreement for 2025 on November 11, 2024, actually constitutes a major transaction under Chapter 14 of the listing rules, rather than merely a disclosable transaction. The company indicated that the relevant percentage exceeds 25% but is less than 100%, thus this ongoing connected transaction is required to comply with the provisions of disclosure, announcement, annual review, circular, and independent shareholder approval. The board of directors includes executive directors Yan Li (Chairman), Yan Yifan (CEO), Li Xiaoshuang, Cao Zhong, as well as non-executive directors Dr. He Yiwu, Mr. Lü Changsheng, and independent non-executive directors Mr. Li Si, Mr. Huang Jiang, and Professor Huang Cibo.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more